Gilead Sciences Inc (GILD)

NASDAQ
Currency in USD
Disclaimer
84.50
+3.11
(+3.82%)
Closed
84.54
+0.04
(+0.05%)
After Hours
Real-time Data
Day's Range
83.62
86.97
52 wk Range
57.17
89.74
Volume
12,790,139
Prev. Close
81.39
Open
84.65
Day's Range
83.62-86.97
52 wk Range
57.17-89.74
Volume
12,790,139
Average Volume (3m)
7,355,434
1-Year Change
29.22%
Shares Outstanding
1,254,243,845
Analysts
Technical
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
86.22
Upside +2.03%

Gilead Sciences Inc News

Gilead Sciences Inc Analysis

Gilead Sciences Inc Company Profile

Gilead Sciences, Inc. is a biopharmaceutical company. The Company is focused on the discovery, development and commercialization of medicine to prevent and treat diseases, including human immunodeficiency virus (HIV), viral hepatitis and cancer. The Company’s products for HIV/AIDS patients include Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/Eviplera, Stribild, and Atripla. Its COVID-19 product is Veklury. The products for liver diseases include Epclusa, Harvoni, Vosevi, Vemlidy, and Viread. The products under hematology/oncology/cell therapy include Yescarta, Tecartus, Trodelvy, and Zydelig. The other products include Letairis (ambrisentan), Ranexa (ranolazine), Cayston, Jyseleca, and AmBisome (amphotericin B liposome for injection). The Company also sells and distributes generic versions of Epclusa and Harvoni in the United States. The Company is also focused on restoring immune balance with agonists targeting immune inhibitory receptors.

Employees
14400